Get In Touch

A drug allergy occurs when a drug component interacts with the human immune system. It is also known as drug hypersensitivity reaction. Allergic reactions to drugs fall under the class of drug hypersensitivity reactions that are mediated by IgE. Recognized risk factors for drug hypersensitivity reactions include gender, age, illnesses, and previous hypersensitivity history to related drugs. Drug allergy is generally diagnosed clinically. Tests like skin tests is carried out in laboratories as it offers high specificity. Treatment is largely helpful and includes termination of the wrong medication, indicative treatment, and patient learning. For instance, patients with allergy from penicillin are advised to avoid any carbapenems and cephalosporins drugs for safer health.

The global drug allergy market can be segmented based on diagnosis, type, treatment, and end-user. In terms of diagnosis, the market can be categorized into blood tests, skin tests, patch test, and others. Based on type, the global drug allergy market can be bifurcated into immunologic and non-immunologic. Immunologic is divided into type I, type II, type III, and type IV reactions. Non-immunologic allergy is divided into predictable and unpredictable allergies. Predictable allergy can be due to multiple reasons such as pharmacologic side effect, drug-drug interactions, secondary pharmacologic side effect, drug toxicity, and drug overdose. Unpredictable allergy can be due to intolerance, alterations in the metabolism, and idiosyncrasy reactions. In terms of treatment, the market can be segmented into corticosteroids, antihistamines, treatment of anaphylaxis, withdrawal of the drug, and others. Based on end-user, the global drug allergy market can be segmented into hospitals, medical research centers, clinics, academic institutes, and others.

Introduction of novel treatment techniques, increase in awareness about various allergies, and rise in demand in emerging markets drive the global drug allergy market. Discovery of new products and rigorous ongoing research for the prevention of any type of drug allergies are major drivers for the market. The global drug allergy market is growing at a moderate pace and the trends is expected to continue during the forecast period.

Geographically, the global drug allergy market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global drug allergy market. The U.S. is the largest market for drug allergy treatment in North America in terms of revenue. According to a study, around 10% of the population of the U.S. has allergies to different kinds of drugs. Europe is the second largest market for drug allergy treatment due to increasing cases of drug allergy and less stringent regulatory authorities in different regions. Countries in Western Europe such as Germany, the U.K., and France dominate the drug allergy market in Europe. Rise in drug allergy cases is one of the major factors driving the market in Europe. The market in Asia Pacific is projected to grow at a rapid pace. Availability of more treatment options and increasing awareness about different types of allergies propel the market in the region. Japan accounts for major share of the market in Asia Pacific. The market in China is expected to witness rapid growth during the forecast period. Improving health care practices and increase in patient involvement fuel the growth of the market in the region. The drug allergy market in Latin America is also growing considerably. Countries such as Brazil and Argentina account for major market share. The market in Middle East & Africa is expected to witness sluggish growth due to lack of awareness about diseases, and traditional health care practices. The Middle East region dominates over African market due to several reasons like developed healthcare facilities and government support to improve public health.

Top players in the global drug allergy market are Bayer, HAL Allergy Group, Circassia, AstraZeneca, MAGNA Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., and Stallergenes Greer plc.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Drug Allergy Market

Pre Book